OR WAIT null SECS
June 07, 2019
The acquisition will boost Biogen’s gene-therapy pipeline with the addition of two mid- to late-stage clinical assets and preclinical programs.
June 06, 2019
European midmarket private equity group, Duke Street, has agreed to acquire Kent Pharmaceuticals and Athlone Laboratories from DCC Vital.
May 28, 2019
Eli Lilly is set to acquire exclusive worldwide rights for potential non-opioid treatment CNTX-0290 from Centrexion Therapeutics in a deal potentially worth $997.5 million.
May 16, 2019
The acquisition of GlaxoSmithKline’s manufacturing site in Cork, Ireland, will expand Thermo Fisher Scientific’s global footprint for complex API manufacturing.
May 15, 2019
The acquisition provides Valby, Denmark-based Lundbeck with a discovery platform and a US-based research hub.
May 13, 2019
The acquisition will expand Pfizer’s rare disease portfolio with an early pipeline candidate for treating dwarfism.
May 10, 2019
Research Point Global and WuXi Clinical Development Services have revealed that they are to combine and rebrand as a new CRO, WuXi Clinical.
Novartis will acquire assets associated with Takeda Pharmaceuticals’ Xiidra (lifitegrast ophthalmic solution) 5%, an eye-care drug.
May 07, 2019
The acquisition is expected to strengthen SGS’s agriculture, food, and life business in the United States.
April 24, 2019
Eli Lilly sold rights to two of its legacy antibiotics as well as its Suzhou, China, manufacturing facility, to China-based specialty pharmaceutical company Eddingpharm in a deal worth $375 million.